. 2017 Jun 27;6:76. doi: 10.4103/2277-9175.209049
Copyright: © 2017 Advanced Biomedical Research
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Figure 2.
Raltitrexed (a) and gefitinib (b)